Search Vaccine Injury Help Center

Nanoparticles Enhance Immune Response, Potential Increase In Adverse Reactions Too?

Vaccines are a weakened or deactivated copy of a virus, injected to stimulate the body’s immune response to a that specific virus. Additional substances, called adjuvants, are added to the vaccine to boost its efficiency. Currently, these adjuvants do not travel well through the lymph system, remaining at the injection site where they trigger an inflammatory response from mast cells in the skin. This mode of activation could be be much more effective if the particles could travel to the lymph nodes.

In the normal course of immune response, mast cells in the body produce granules that contain a chemical called tumor necrosis factor (TNF). These granules deposit TNF as well as other immune-response “mediators” that wait for an infecting pathogen to attack. The Duke team’s goal was to develop a synthetic adjuvant that could mimic these granules and deliver them immediately to the lymph nodes, speeding immune responses when combined with the vaccine.

To test their hypothesis, researchers engineered granules made of a carbohydrate backbone containing tiny capsules of TNF. They vaccinated mice with a vaccine for influenza A that was enhanced with the granules, then infected the mice with a lethal dose of the virus. The mice showed a stronger immune response and better survival rates compared to mice that did not receive the new adjuvant. Additionally, researchers found that they could further engineer the granules, adding a cytokine called IL-12, creating an even more specialized immune response to infection.

Armed with these findings, the Duke University team is poised to take new steps toward applying them in humans, paving the way for future development of unique, medically-personalized vaccines.

Supporting references for this study may be found here:

http://www.bbc.co.uk/news/health-16654182#story_continues_1

http://www.nature.com/nmat/journal/vaop/ncurrent/full/nmat3222.html

http://www.dukehealth.org/health_library/news/vaccines-to-boost-immunity-where-it-counts-not-just-near-shot-site

Find More Articles On These Topics:

Comments

Contact Our Vaccine Injury Lawyers. GET HELP NOW !
At Law Offices of Sadaka Associates, we can assure you that we will fight to get you the compensation you deserve. Our Vaccine Injury Lawyers are standing by to assist you. In most instances you only have three years from the date of injury to file a claim in vaccine court or two years from the date of death. Contact us today, toll-free, at 1-800-810-3457 or fill out our online form for a free case evaluation.
Vaccine News
Pregnant Nurse Fired for Refusing Flu Shot
A pregnant woman was fired for refusing to receive a flu vaccine that she thought could potentially harm her unborn child. The woman is 29-year-old Dreonna Breton, a nurse working at Horizon Healthcare...
 
Merck Issues Voluntary Recall on Gardasil Vaccine
More than half a million Gardasil vaccinations have been recalled due to glass particle contamination. The Center for Disease Control and Prevention reported via a news release on December 20, 2013 that the...
 
A New Vaccine Launched For Typhoid
Typhoid is a life threatening illness caused by the bacterium Samlonella Typi, which is transmitted through food or drink contaminated by the feces or urine of the infected person. According to the CDC...
Measles Outbreak Reported in Texas - Is Fear of MMR to Blame?
A measles outbreak in Texas has doctors all across the state worried and alert for patients who show signs of infections. The Texas Department of State Health Services asked people to seek immunizations...
 
New HIV Vaccine To Be Tested On Rhesus Monkeys
Recently, many discussions about a developing HIV vaccine have taken place. A research team began working on a vaccine for HIV in 2001 wanting to cure the world wide pandemic affecting 33 million people today....
 
The HPV Vaccine Has Been Reduced To Two Doses In Quebec
According to the CDC, the HPV vaccine is recommended to boys and girls starting from age 9 and is administered in a series of three doses.  However, new research shows that a third dose may not be needed....